A “vicious cycle” of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?
Open Access
- 1 May 2013
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 2 (5) , e23850
Abstract
Receptor activator of NFκB ligand (RANKL) is mainly known for its role in bone metabolism, constituting a target for therapeutic interventions. Increasing evidence suggests that RANKL is also invol...Keywords
This publication has 10 references indexed in Scilit:
- RANKL Expression, Function, and Therapeutic Targeting in Multiple Myeloma and Chronic Lymphocytic LeukemiaCancer Research, 2013
- Receptor Activator for NF-κB Ligand in Acute Myeloid Leukemia: Expression, Function, and Modulation of NK Cell ImmunosurveillanceThe Journal of Immunology, 2013
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumabNature Reviews Drug Discovery, 2012
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signallingNature, 2011
- Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophagesNature Immunology, 2007
- Role of the RANKL/RANK system in the induction of interleukin‐8 (IL‐8) in B chronic lymphocytic leukemia (B‐CLL) cellsJournal of Cellular Physiology, 2005
- Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo.2003
- Enhanced Secretion of IFN-γ by Activated Th1 Cells Occurs Via Reverse Signaling Through TNF-Related Activation-Induced CytokineThe Journal of Immunology, 2001
- TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival FactorJournal of Experimental Medicine, 1997
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997